Table 1 Patient and tumor characteristics
Characteristics | |||
|---|---|---|---|
Age (in years) | Mean | 56 | |
Median | 55 | ||
Range | 30-89 | ||
Follow up (in months) | Mean | 54 | |
Median | 49 | ||
Range | 24-108 | ||
N | % | ||
Sex | Male | 57 | 84% |
Female | 11 | 16% | |
Total | 68 | 100% | |
Group stage | I* | 1 | 1.5% |
II | 3 | 4.4% | |
III | 8 | 11.8% | |
IV | 52 | 76.47% | |
Total | 68 | 100% | |
T status | T0 | 10 | 14.7% |
T1 | 11 | 16.2% | |
T2 | 26 | 38.2% | |
T3 | 10 | 14.7% | |
T4 | 11 | 16.2% | |
Total | 68 | 100% | |
N stage | N0 | 13 | 19.1% |
N1 | 8 | 11.8% | |
N2 | 42 | 61.8% | |
N3 | 5 | 7.4% | |
Total | 68 | 100% | |
Primary tumor site | Oral Cavity | 6 | 8.8% |
Oropharynx | 33 | 48.5% | |
Nasopharynx | 9 | 13.2% | |
Hypopharynx | 3 | 4.4% | |
Larynx | 7 | 10.3% | |
Unknown Primary | 10 | 14.7% | |
Total | 68 | 100% | |
Aim of treatment | Definitive | 50 | 73.5% |
Adjuvant + Postop | 18 | 26.5% | |
Total | 68 | 100% | |
Chemotherapy | Yes | 59 | 86.8% |
No | 9 | 13.2% | |
Total | 68 | 100% |